Literature DB >> 2396193

Carcinoma of the main hepatic duct junction: indications, operative morbidity and mortality, and long-term survival.

T Tsuzuki1, M Ueda, S Kuramochi, S Iida, S Takahashi, H Iri.   

Abstract

Carcinoma of the main hepatic duct junction tends to spread extensively along the hepatic ducts into the liver parenchyma. Therefore extensive resection of the bile ducts combined with hepatic resection is the procedure of choice. Between January 1973 and April 1989, 25 of 50 patients with this type of carcinoma underwent resection, a resectability rate of 50%. One patient died of staphylococcal sepsis on the postoperative day 42 after right trisegmentectomy and resection of the bile ducts, a hospital death rate of 4%. Twenty-four patients were discharged from the hospital. The 5-year actuarial survival rate calculated by the Kaplan-Meier method was 19%. Four patients lived longer than 5 years after surgery; the longest survival was 9 years after right trisegmentectomy and resection of the bile ducts. These four patients had clear margins at the resected bile ducts. This article was designed to clarify the point at issue by presenting our results in terms of indications, operative morbidity and mortality, and long-term survival.

Entities:  

Mesh:

Year:  1990        PMID: 2396193

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  13 in total

1.  Changing trends of surgical treatment of hilar bile duct cancer: clinical and experimental perspectives.

Authors:  Zhi-Qiang Huang; Ning-Xin Zhou; Da-Dong Wang; Jian-Guo Lu; Ming-Yi Chen
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

Review 2.  Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection.

Authors:  T Kosuge; J Yamamoto; K Shimada; S Yamasaki; M Makuuchi
Journal:  Ann Surg       Date:  1999-11       Impact factor: 12.969

3.  Resection of hilar cholangiocarcinomas: pivotal prognostic factors and impact of tumor sclerosis.

Authors:  Harald Puhalla; Thomas Gruenberger; Herwig Pokorny; Thomas Soliman; Fritz Wrba; Ulrike Sponer; Thomas Winkler; Meinhard Ploner; Markus Raderer; Rudolf Steininger; Ferdinand Mühlbacher; Friedrich Laengle
Journal:  World J Surg       Date:  2003-05-13       Impact factor: 3.352

4.  Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.

Authors:  A Nakeeb; H A Pitt; T A Sohn; J Coleman; R A Abrams; S Piantadosi; R H Hruban; K D Lillemoe; C J Yeo; J L Cameron
Journal:  Ann Surg       Date:  1996-10       Impact factor: 12.969

5.  Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases.

Authors:  Tomoki Ebata; Masato Nagino; Junichi Kamiya; Katsuhiko Uesaka; Tetsuro Nagasaka; Yuji Nimura
Journal:  Ann Surg       Date:  2003-11       Impact factor: 12.969

6.  Improvements in survival by aggressive resections of hilar cholangiocarcinoma.

Authors:  H U Baer; S C Stain; A R Dennison; B Eggers; L H Blumgart
Journal:  Ann Surg       Date:  1993-01       Impact factor: 12.969

7.  Second cancer during long-term survival after resection of biliary tract carcinoma.

Authors:  S Nakamura; S Suzuki; T Sakaguchi; H Konno; S Baba; I Kosugi; H Muro
Journal:  J Gastroenterol       Date:  1996-04       Impact factor: 7.527

8.  Surgical treatment of carcinoma of the hepatic duct confluence: analysis of 55 resected carcinomas.

Authors:  Y Ogura; R Mizumoto; M Tabata; S Matsuda; T Kusuda
Journal:  World J Surg       Date:  1993 Jan-Feb       Impact factor: 3.352

9.  Combined portal vein resection for hilar cholangiocarcinoma.

Authors:  Tao Bai; Jie Chen; Zhi-Bo Xie; Liang Ma; Jun-Jie Liu; Shao-Liang Zhu; Fei-Xiang Wu; Le-Qun Li
Journal:  Int J Clin Exp Med       Date:  2015-11-15

10.  Early mortality in 100 consecutive liver resections in 96 patients with benign and malignant liver tumours.

Authors:  N A Habib
Journal:  Ann R Coll Surg Engl       Date:  1995-03       Impact factor: 1.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.